{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:52:18Z","timestamp":1791845538745,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Health Technology R&D Project","award":["HI14C0257"],"award-info":[{"award-number":["HI14C0257"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijantimicag.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T21:18:16Z","timestamp":1479763096000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antimicrobial activity of novel 4 H -4-oxoquinolizine compounds against extensively drug-resistant Acinetobacter baumannii strains"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-9150","authenticated-orcid":false,"given":"Seok Hyeon","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Il","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gati Noble","family":"Selasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiimwe","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Soo","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nrmicro1789","article-title":"An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii","volume":"5","author":"Dijkshoorn","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciq154","article-title":"Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia","volume":"52","author":"Chuang","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0020","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/iub.534","article-title":"Acinetobacter infection\u2014an emerging threat to human health","volume":"63","author":"Visca","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2009.02.010","article-title":"Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals","volume":"64","author":"Cho","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12879-015-1297-x","article-title":"Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data","volume":"15","author":"Oikonomou","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2015.09.001","article-title":"Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital","volume":"36","author":"Selasi","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0045","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0055","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/jm990191k","article-title":"Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 position","volume":"42","author":"Ma","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1381612802666220921174531","article-title":"Type II DNA topoisomerases as antibacterial targets","volume":"2","author":"Shen","year":"1996","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0065","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1021\/jm960207w","article-title":"Synthesis and structure\u2013activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents","volume":"39","author":"Li","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0070","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1074\/jbc.272.14.9401","article-title":"Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV","volume":"272","author":"Marians","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2016.10.008_bib0075","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1021\/bi00435a039","article-title":"Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug\u2013DNA binding model","volume":"28","author":"Shen","year":"1989","journal-title":"Biochemistry"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:31:36Z","timestamp":1692577896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916303442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0924857916303442"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of novel 4H-4-oxoquinolizine compounds against extensively drug-resistant Acinetobacter baumannii strains","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}